Head Cancer Clinical Trial
Official title:
Evaluation of Quality of Life and Self-assurance and Social Support Earned in Patients Before and After Operation for Non-cellular Head Cancer and Cancer in the First, Second and Third Stages of Advance
| NCT number | NCT06395805 |
| Other study ID # | 31/2023 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 15, 2023 |
| Est. completion date | December 31, 2024 |
Research objectives: - To evaluate the quality of life of patients before and after surgery for benign head tumors ( meningiomas) and malignant tumors at stage I, II and III, to assess whether it depends on the size of the tumor, type of tumor, malignancy and its location - evaluation of the independence of patients before and after surgery for head tumors at different stages of the disease - benign tumors (meningiomas) and malignant tumors in stage I, II and III, evaluation of what factors affected the different independence of patients - Multidimensional evaluation of perceived social support of patients before and after surgery for head cancers - benign ( meningiomas) and malignant tumors in stage I, II and III, taking into account three sources of support: significant person, family and friends Scientific (research) problems: - What is the quality of life of patients before and after surgery for benign ( meningiomas) and malignant head cancers at stages I, II and III ? Is quality of life in patients with head cancer dependent on tumor size, malignancy, location or type of cancer ?
| Status | Recruiting |
| Enrollment | 100 |
| Est. completion date | December 31, 2024 |
| Est. primary completion date | June 15, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion criteria for the study: -clinical diagnosis of head cancer Study exclusion criteria: - cranio-brain injuries and inflammatory brain diseases. |
| Country | Name | City | State |
|---|---|---|---|
| Poland | St. Raphael's Hospital | Krakow | Lesserpoland |
| Lead Sponsor | Collaborator |
|---|---|
| Andrzej Frycz Modrzewski Krakow University |
Poland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Quality of life assessed using The World Health Organization Quality of Life (WHOQOL) scale. Social support assessed using Zimet's Multidimensional Perceived Social Support Scale. Patient self-efficacy as assessed by the Lawton I-ADL scale and AIS scale. | Quality of life assessed using The World Health Organization Quality of Life (WHOQOL-BREF) scale questionnaire which contains 26 questions analyzing four domains of life and separately perception of quality of life and self-assessment of health status.
It is used to assess the quality of life of both healthy and sick people in clinical practice and addresses the following domains of quality of life: somatic functioning, psychological functioning, social functioning and community functioning. Social support assessed using Zimet's Multidimensional Perceived Social Support Scale - the original version on the MSPSS. Patients' self-efficacy assessed by the I-ADL scale according to Lawton, where the patient answers nine questions regarding activities of daily living. Disease acceptance scale according to the AIS questionnaire, where the patient answers eight questions regarding their disease. |
12 months to 24 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00318890 -
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05420948 -
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
|
Phase 2 | |
| Completed |
NCT00798655 -
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
|
Phase 2 | |
| Completed |
NCT02714920 -
DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD)
|
N/A | |
| Completed |
NCT01194466 -
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)
|
N/A | |
| Recruiting |
NCT05549414 -
Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System
|
N/A | |
| Recruiting |
NCT04750434 -
PET MRI as a Staging Tool for Head and Neck Cancer
|
||
| Withdrawn |
NCT05472506 -
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT04261179 -
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
|
Phase 4 | |
| Recruiting |
NCT04673981 -
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
|
N/A | |
| Not yet recruiting |
NCT05946577 -
Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study
|
||
| Completed |
NCT02738268 -
Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients
|
N/A | |
| Recruiting |
NCT04722523 -
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
|
Phase 1 | |
| Enrolling by invitation |
NCT04905030 -
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
|
N/A | |
| Recruiting |
NCT03809208 -
Birinapant and Intensity Modulated Re-Irradiation Therapy for Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma
|
Phase 1 |